Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Abiomed Inc. buy melinda

Start price
€177.80
01.12.19 / 50%
Target price
€300.00
04.11.21
Performance (%)
49.94%
End price
€266.60
29.04.21
Summary
This prediction ended on 29.04.21 with a price of €266.60. With a performance of 49.94% the BUY prediction by melinda was a big success. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Abiomed Inc. - - - -
iShares Core DAX® 2.112% -0.367% 13.466% 16.854%
iShares Nasdaq 100 -2.197% -3.794% 38.426% 42.934%
iShares Nikkei 225® -1.555% -7.320% 18.451% 2.941%
iShares S&P 500 -0.472% -2.078% 27.488% 41.955%

According to melinda what are the pros and cons of Abiomed Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Abiomed Inc. diskutieren

Buy Abiomed Inc.

Prediction Buy
Perf. (%) 49.94%
Target price 300.000
Change
Ends at 04.11.21

Kursziel gesetzt auf 300,0

In the thread Trading Abiomed Inc.
Prediction Buy
Perf. (%) 49.94%
Target price 300.000
Change
Ends at 04.11.21

Buy beendet

Stopped prediction by melinda for Abiomed Inc.

buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€238.80
07.06.21
€250.00
29.04.22
15.03%
30.04.22

Could be worthwhile Investment >10% per year
Abiomed Inc.

Start price
Target price
Perf. (%)
€266.60
29.04.21
€245.00
29.04.22
-10.43%
07.06.21

Could be worthwhile Investment >10% per year
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€285.06
18.11.18
€329.23
28.11.18
5.54%
28.11.18

Could be worthwhile Investment >10% per year
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€266.84
09.03.18
€306.68
07.05.18
17.78%
07.05.18

Could be worthwhile Investment >10% per year
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€172.25
21.12.17
€187.35
08.01.18
9.20%
08.01.18

Could be worthwhile Investment >10% per year